Compounds > ng-nitroarginine methyl ester
Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Glioma

ng-nitroarginine methyl ester has been researched along with Glioma in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's8 (50.00)29.6817
2010's4 (25.00)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Ammazzalorso, A; Amoia, P; Amoroso, R; Cataldi, A; De Filippis, B; Di Matteo, M; Di Silvestre, S; Fantacuzzi, M; Gallorini, M; Giampietro, L; Graziani, V; Maccallini, C; Montagnani, M; Pandolfi, A; Potenza, MA; Re, N1
Belgorosky, D; Bhatia, S; Eijan, AM; Higgins, DMO; Hincapie Arias, E; Merenzon, MA; Shah, AH; Villaverde, M1
Chelluboina, B; Chetty, C; Ponnala, S; Rao, JS; Rehman, AA; Veeravalli, KK; Velpula, KK; Zakharian, E; Zhuang, T1
Li, ZQ; Liu, LB; Liu, XB; Liu, YH; Ma, J; Ma, T; Xi, Z; Xue, YX; Zhao, XH1
Fillmore, HL; Pullen, NA1
Hirano, H; Kuratsu, J; Nomoto, M; Oyoshi, T1
Chen, ZL; Gao, RL1
Arcuri, E; Arese, M; Bacchi, A; Cardelli, P; Citro, G; Mastronicola, D; Mercadante, S; Sarti, P1
Eichler, M; Goncharov, I; Isaac, A; Shainberg, A; Shmist, YA; Shneyvays, V; Vogel, Z1
Badn, W; Darabi, A; Esbjörnsson, M; Fellert, MA; Hegardt, P; Janelidze, S; Salford, LG; Siesjö, P; Smith, KE; Visse, E1
Black, KL; Matsukado, K; Nakano, S1
Avina, MD; Jadus, MR; Kim, S; Liu, Y; Lowell, CA; Ly, M; Narasaki, R; Wepsic, HT; Williams, CC1
Kelly, PA; Malcolm, GP; Ritchie, I; Swaroop, GR; Whittle, IR1
Hegardt, P; Sjögren, HO; Widegren, B1
Chou, H; Hsu, CY; Thompson, EM; Xu, J; Yang, DI; Yin, JH1
Bell, HS; Kelly, PA; Shinoda, J; Swaroop, GR; Whittle, IR; Yamaguchi, S1

Reviews

1 review(s) available for ng-nitroarginine methyl ester and Glioma

ArticleYear
Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review.
    Nitric oxide : biology and chemistry, 2023, 09-01, Volume: 138-139

    Topics: Animals; Brain Neoplasms; Enzyme Inhibitors; Glioblastoma; Glioma; Humans; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Temozolomide

2023

Other Studies

15 other study(ies) available for ng-nitroarginine methyl ester and Glioma

ArticleYear
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-l-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma.
    European journal of medicinal chemistry, 2018, May-25, Volume: 152

    Topics: Amidines; Animals; Antineoplastic Agents; Cell Cycle; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Glioma; Male; Mesenteric Arteries; Molecular Docking Simulation; Molecular Structure; Nitric Oxide Synthase Type II; Proline; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship

2018
Involvement of nitric oxide synthase in matrix metalloproteinase-9- and/or urokinase plasminogen activator receptor-mediated glioma cell migration.
    BMC cancer, 2013, Dec-11, Volume: 13

    Topics: Animals; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Enzyme Inhibitors; Gene Expression; Glioma; Heterografts; Humans; Integrins; Matrix Metalloproteinase 9; Mice; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Binding; Receptors, Urokinase Plasminogen Activator; RNA Interference

2013
Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin.
    Biochemical and biophysical research communications, 2015, Aug-14, Volume: 464, Issue:1

    Topics: Animals; Blood-Brain Barrier; Bradykinin; Brain Neoplasms; Claudin-5; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Glioma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Occludin; Permeability; Promoter Regions, Genetic; Protein Binding; Protein Transport; Rats; Rats, Wistar; Signal Transduction; Tight Junctions; Transcription Factors; Vasodilator Agents

2015
Induction of matrix metalloproteinase-1 and glioma cell motility by nitric oxide.
    Journal of neuro-oncology, 2010, Volume: 96, Issue:2

    Topics: Analysis of Variance; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioma; Humans; Matrix Metalloproteinase 1; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; RNA, Messenger; RNA, Small Interfering; Transfection

2010
Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:1

    Topics: Animals; Brain Neoplasms; Enzyme Inhibitors; Glioma; Half-Life; Immunohistochemistry; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paraffin Embedding; Rats; Rats, Wistar; Thiazines

2003
[Suppression of nitric oxide on cytotoxicity of Lomustine in glioma cell line BT- 325].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2003, Volume: 32, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioma; Humans; Interleukin-1; Lipopolysaccharides; Lomustine; NG-Nitroarginine Methyl Ester; Nitric Oxide

2003
Morphine but not fentanyl and methadone affects mitochondrial membrane potential by inducing nitric oxide release in glioma cells.
    Cellular and molecular life sciences : CMLS, 2004, Volume: 61, Issue:23

    Topics: Adjuvants, Anesthesia; Analgesics, Opioid; Cell Line, Tumor; Electron Transport Complex IV; Fentanyl; Free Radicals; Glioma; Humans; Membrane Potentials; Methadone; Microscopy, Fluorescence; Mitochondria; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Signal Transduction; Spectrophotometry; Time Factors

2004
Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production.
    Molecular and cellular biochemistry, 2006, Volume: 283, Issue:1-2

    Topics: Actins; Analgesics, Non-Narcotic; Animals; Animals, Newborn; Dronabinol; Glioma; Hypoxia; L-Lactate Dehydrogenase; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Tumor Cells, Cultured

2006
Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
    Scandinavian journal of immunology, 2007, Volume: 65, Issue:3

    Topics: Animals; B-Lymphocytes; Brain Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Enzyme Inhibitors; Flow Cytometry; Glioma; Immunotherapy; Interferon-gamma; Lysine; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344

2007
Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
    Cancer research, 1996, Sep-01, Volume: 56, Issue:17

    Topics: Aminoisobutyric Acids; Animals; Arginine; Blood-Brain Barrier; Blotting, Western; Bradykinin; Brain Neoplasms; Capillary Permeability; Carbon Radioisotopes; Dextrans; Enzyme Inhibitors; Female; Glioma; Immunohistochemistry; Infusions, Intra-Arterial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tumor Cells, Cultured

1996
Macrophages kill T9 glioma tumor cells bearing the membrane isoform of macrophage colony stimulating factor through a phagocytosis-dependent pathway.
    Journal of immunology (Baltimore, Md. : 1950), 1998, Jan-01, Volume: 160, Issue:1

    Topics: Animals; Bone Marrow Cells; Cell Membrane; Cytotoxicity, Immunologic; Glioma; Macrophage Activation; Macrophage Colony-Stimulating Factor; Macrophages; Membrane Proteins; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Time Factors; Transfection; Tumor Cells, Cultured

1998
Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma.
    Neuroreport, 1998, Aug-03, Volume: 9, Issue:11

    Topics: Animals; Autoradiography; Brain Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Enzyme Inhibitors; Glioma; Molsidomine; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats

1998
Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas.
    Cellular immunology, 2000, Mar-15, Volume: 200, Issue:2

    Topics: Animals; CD3 Complex; Cell Division; Cytotoxicity, Immunologic; Disease Progression; Enterotoxins; Glioma; Immune Tolerance; Injections, Intraperitoneal; Kinetics; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred F344; Spleen; Superantigens; T-Lymphocytes; Tumor Cells, Cultured

2000
Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:1

    Topics: Animals; Antineoplastic Agents, Alkylating; Antisense Elements (Genetics); Carmustine; Drug Resistance, Neoplasm; Glioma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Tumor Cells, Cultured

2001
The effects of chronic nitric oxide synthase suppression on glioma pathophysiology.
    British journal of neurosurgery, 2000, Volume: 14, Issue:6

    Topics: Animals; Brain Neoplasms; Cerebrovascular Circulation; Drug Administration Schedule; Enzyme Inhibitors; Glioma; Necrosis; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Regional Blood Flow

2000